Dr Elizabeth Moore is Research Fellow and Project Manager of the Myeloma and Related Diseases Registry (MRDR) with the Transfusion Research Unit, SPHPM; she has been instrumental in the growth and increasing productivity of the registry.

Elizabeth completed a critical care-related post-doctoral Research Fellowship with the Australian and New Zealand Intensive Care (ANZIC) Research Centre where she conducted her PhD investigating potential treatments for, and early markers of acute kidney injury in patients with traumatic brain injury. This involved conducting the Renal Substudies of the EPO-TBI and POLAR multicentre clinical trials. Elizabeth has completed a biostatistics/epidemiology streamed Master of Public Health, has extensive experience as a critical care nurse, has worked as Research Coordinator in the Royal Melbourne Hospital ICU and Victorian Infectious Diseases Service, managed the ANTISEPSIS substudy of the ASPREE trial, and is a member of the Research Advisory Panel of the Australian College of Critical Care Nurses (ACCCN).

Elizabeth has led the My-PROMPT trial, a randomised controlled trial to test the feasibility of real-time reporting of patient-reported outcomes in patients with multiple myeloma to treating clinicians, and is involved in numerous MRDR research projects http://www.mrdr.net.au/projects/ including the IMPROVE study.

Research Projects

Myeloma and Related Diseases Registry   http://www.mrdr.net.au/

My-PROMPT: Patient Reported Outcome Measures in multiple myeloma: real-time rePorTing to improve care   http://www.mrdr.net.au/projects/

IMPROVE: Immunoglobulins in Myeloma Patients: Research into Outcomes, Variation in practice, and Epidemiology   http://www.mrdr.net.au/projects/

Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR)   https://apacmrdr.org/